I'm not trying to "upsurp" anything. I'm just stating what I'm reading, and adding the links to them.

In 2006 the FDA approved Erbitux for use in combination of SCCHN that cannot be removed by by surgery (unresectable). It was also approved for use alone (mono therapy) to treat patients whose head and neck cancer has spread (metastasized) despite the use of standard chemotherapy.

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108609.htm

Also, Erbitux was then approved by the FDA in 2011 for use with chemotherapy to treat patients with late stage (Metatastic) head and neck cancer.

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm278894.htm

Accoring to these news releases by the FDA, unless they made an ammedndum since, waiver, agreement, who is upsurping who, the NCCN?

Amyway, I had Erbitux and taxotere ending last November.

10/09 T1N2bM0 Tonsil
11/09 Taxo Cisp 5-FU, 6 Months Hosp
01/11 35 IMRT 70Gy 7 Wks
06/11 30 HBO
08/11 RND PNI
06/12 SND PNI LVI
08/12 RND Pec Flap IORT 12 Gy
10/12 25 IMRT 50Gy 6 Wks Taxo Erbitux
10/13 SND
10/13 TBO/Angiograph
10/13 RND Carotid Remove IORT 10Gy PNI
12/13 25 Protons 50Gy 6 Wks Carbo
11/14 All Teeth Extract 30 HBO
03/15 Sequestromy Buccal Flap ORN
09/16 Mandibulectomy Fib Flap Sternotomy
04/17 Regraft hypergranulation Donor Site
06/17 Heart Attack Stent
02/19 Finally Cancer Free Took 10 yrs